Recap: Catalyst Biosciences Q1 Earnings

 

Catalyst Biosciences CBIO reported its Q1 earnings results on Monday, May 9, 2022 at 08:30 AM.

Here's what investors need to know about the announcement.

Earnings

Catalyst Biosciences missed estimated earnings by 4.55%, reporting an EPS of $-0.46 versus an estimate of $-0.44.

Revenue was down $673.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 0.02% increase in the share price the next day.

Here's a look at Catalyst Biosciences's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.59 -0.66 -0.69 -0.64
EPS Actual -0.65 -0.80 -0.64 -0.79
Revenue Estimate 170.00K 670.00K 330.00K 970.00K
Revenue Actual 2.44M 2.30M 1.13M 1.47M

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Catalyst Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!